BLTE
BELITE BIO, INC
NASDAQ · Healthcare · Biotechnology · US
$150.28
+1.05%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-13.2%
Return on equity
-12.9%
Return on assets
-15.3%
Return on invested capital
0.00x
Asset turnover
-$10.4K
Cash from operations
$0.00
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026